|
Server : Apache/2.4.62 System : FreeBSD fbsdweb2.web.rcn.net 14.1-RELEASE FreeBSD 14.1-RELEASE releng/14.1-n267679-10e31f0946d8 GENERIC amd64 User : www ( 80) PHP Version : 8.3.8 Disable Function : NONE Directory : /domains/bluerae/clients/amag/staging/about/ |
Upload File : |
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>Board of Directors: AMAG Pharmaceuticals</title>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
<meta name="keywords" content="intravenous iron, iron deficiency, iron deficiency anemia, chronic kidney disease" />
<meta name="description" content="The Management Team at AMAG Pharmaceuticals, Inc. has extensive experience in the biopharmaceutical industry." />
<link type="text/css" rel="stylesheet" href="../css/styles.css" media="all" />
<script type="text/javascript" src="http://ajax.googleapis.com/ajax/libs/jquery/1.8.3/jquery.min.js"></script>
<script type="text/javascript">window.jQuery || document.write('<script src="../js/jquery-1.8.3.min.js"><\/script>')</script>
<script type="text/javascript" src="../js/jquery.main.js"></script>
<script type="text/javascript" src="//use.typekit.net/ebh7nzk.js"></script>
<script type="text/javascript">try{Typekit.load();}catch(e){}</script>
<!-- styles and scripts for leadership team lightboxes -->
<link rel="stylesheet" href="../css/bio.css" />
<link rel="stylesheet" href="../css/colorbox.css" />
<script src="https://ajax.googleapis.com/ajax/libs/jquery/1.10.2/jquery.min.js"></script>
<script src="../js/jquery.colorbox.js"></script>
<script>
$(document).ready(function(){
//Examples of how to assign the Colorbox event to elements
$(".group1").colorbox({rel:'group1'});
$(".group2").colorbox({rel:'group2', transition:"fade"});
$(".group3").colorbox({rel:'group3', transition:"none", width:"75%", height:"75%"});
$(".group4").colorbox({rel:'group4', slideshow:true});
$(".ajax").colorbox();
$(".youtube").colorbox({iframe:true, innerWidth:640, innerHeight:390});
$(".vimeo").colorbox({iframe:true, innerWidth:500, innerHeight:409});
$(".iframe").colorbox({iframe:true, width:"80%", height:"80%"});
$(".inline").colorbox({inline:true, width:"50%"});
$(".callbacks").colorbox({
onOpen:function(){ alert('onOpen: colorbox is about to open'); },
onLoad:function(){ alert('onLoad: colorbox has started to load the targeted content'); },
onComplete:function(){ alert('onComplete: colorbox has displayed the loaded content'); },
onCleanup:function(){ alert('onCleanup: colorbox has begun the close process'); },
onClosed:function(){ alert('onClosed: colorbox has completely closed'); }
});
$('.non-retina').colorbox({rel:'group5', transition:'none'})
$('.retina').colorbox({rel:'group5', transition:'none', retinaImage:true, retinaUrl:true});
//Example of preserving a JavaScript event for inline calls.
$("#click").click(function(){
$('#click').css({"background-color":"#f00", "color":"#fff", "cursor":"inherit"}).text("Open this window again and this message will still be here.");
return false;
});
});
</script>
</head>
<body>
<!-- wrapper -->
<div class="wrapper">
<div class="w1">
<!-- header -->
<div id="header">
<!-- logotype -->
<strong class="logo"><a href="../index.html">AMAG Pharmaceuticals<img src="../images/colorbox_overlay.png" width="30" height="30" /></a></strong>
<div class="nav-holder">
<!-- top-navigation -->
<ul class="top-nav">
<li><a href="../about/contact.html">contact</a></li>
<li><a href="../search/index.html">search</a></li>
<li><a href="../search/sitemap.html">sitemap</a></li>
</ul>
<!-- navigation -->
<div class="nav-container">
<ul id="nav">
<li>
<a href="../about/index.html" class="current">about us</a>
<div class="drop">
<ul>
<li><a href="../about/mission.html">mission</a></li>
<li><a href="../about/leadership.html">leadership team</a></li>
<li><a href="../about/board.html">board of directors</a></li>
<li><a href="../about/directions.html">directions</a></li>
<li><a href="../about/contact.html">contact us</a></li>
</ul>
</div>
</li>
<li>
<a href="../products/index.html">products</a>
<div class="drop">
<ul>
<li><a href="../products/feraheme.html">Feraheme</a></li>
<li><a href="../products/mugard.html">MuGard</a></li>
</ul>
</div>
</li>
<li>
<a href="../collaborations/index.html">collaborations</a>
<div class="drop">
<ul>
<li><a href="../collaborations/business.html">partners</a></li>
</ul>
</div>
</li>
<li>
<a href="../community/index.html">community</a>
<div class="drop">
<ul>
<li><a href="../community/corporate.html">corporate giving</a></li>
</ul>
</div>
</li>
<li>
<a href="http://ir.amagpharma.com/phoenix.zhtml?c=61596&p=irol-irhome">investors</a>
<div class="drop">
<ul>
<li><a href="http://ir.amagpharma.com/phoenix.zhtml?c=61596&p=irol-news&nyo=0">press releases</a></li>
<li><a href="http://ir.amagpharma.com/phoenix.zhtml?c=61596&p=irol-calendar">investor events</a></li>
<li><a href="http://ir.amagpharma.com/phoenix.zhtml?c=61596&p=irol-reportsother">financial reports</a></li>
<li><a href="http://ir.amagpharma.com/phoenix.zhtml?c=61596&p=irol-sec">SEC filings</a></li>
<li><a href="http://ir.amagpharma.com/phoenix.zhtml?c=61596&p=irol-stockquote">stock information</a></li>
<li><a href="http://ir.amagpharma.com/phoenix.zhtml?c=61596&p=irol-govhighlights">corporate governance</a></li>
<li><a href="http://ir.amagpharma.com/phoenix.zhtml?c=61596&p=irol-calendar">investor info</a></li>
</ul>
</div>
</li>
<li class="last">
<a href="../careers/index.html">careers</a>
<div class="drop">
<ul>
<li><a href="../careers/values.html">values and culture</a></li>
<li><a href="../careers/highlight.html">employee highlight</a></li>
<li><a href="../careers/benefits.html">benefits</a></li>
<li><a href="../careers/opportunities.html">opportunities</a></li>
</ul>
</div>
</li>
</ul>
</div>
</div>
</div>
<!-- main -->
<div id="main">
<div class="heading-block">
<h1>about us</h1>
</div>
<!-- main-holder -->
<div class="main-holder">
<!-- twocolumns -->
<div id="twocolumns">
<!-- twocolumns content -->
<div id="content" class="wide">
<span class="page-intro">Board of Directors</span>
<div class="management_list_item">
<a href="#popup_narachi" class="inline"><h4>Michael Narachi</h4><p class="managementtitle">Chairman of the Board, AMAG; President and CEO, Orexigen Therapeutics, Inc.</p></a>
</div>
<div class="management_list_item">
<a href="#popup_deptula" class="inline"><h4>Barbara Deptula</h4><p>Former Executive Vice President and Chief Corporate Development Officer of Shire plc.</p></a>
</div>
<div class="management_list_item">
<a href="#popup_heiden" class="inline"><h4>William K. Heiden</h4><p>President and Chief Executive Officer of AMAG</p></a>
</div>
<div class="management_list_item">
<a href="#popup_perez" class="inline"><h4>Robert J. Perez</h4><p>Executive Vice President, Chief Operating Officer, Cubist Pharmaceuticals, Inc.</p></a>
</div>
<div class="management_list_item">
<a href="#popup_russell" class="inline"><h4>Dr. Lesley Russell</h4><p>Former SVP, Head of R&D for Global Branded Products, Teva Pharmaceuticals</p></a>
</div>
<div class="management_list_item">
<a href="#popup_santini" class="inline"><h4>Gino Santini</h4><p>Retired Eli Lilly and Company Executive; Most recently SVP, Corporate Strategy and Business Development</p></a>
</div>
<div class="management_list_item">
<a href="#popup_scoon" class="inline"><h4>Davey S. Scoon</h4><p>Non-Executive Chairman, Board of Directors Tufts Health Plan</p></a>
</div>
<p> </p>
<!-- POPUP Narachi -->
<div class="popupbio" style="display:none">
<div id="popup_narachi">
<div class="popupcontent">
<h2>Michael Narachi</h2>
<h3>Chairman of the Board, AMAG; President and CEO, Orexigen Therapeutics, Inc.</h3>
<p>Michael Narachi has been a director since November 2006.</p>
<p>Mr. Narachi is currently President and CEO of Orexigen Therapeutics, Inc. Prior to joining Orexigen in 2009, he served as Chairman, Chief Executive Officer and President of Ren Pharmaceuticals, Inc. from 2006 to 2009. From 2002 to 2008, Mr. Narachi served as Chairman of the Board of Directors of Naryx Pharma, Inc. In 2004, Mr. Narachi retired as an officer and Vice President of Amgen Inc., where he served as General Manager of Amgen's Anemia Business from 1999 to 2003. Mr. Narachi joined Amgen in 1984 and held various positions throughout the organization including: Product Development Team Leader for NEUPOGEN®; Director of Clinical Operations in Thousand Oaks, CA and Cambridge, UK; Vice President of Development and Representative Director for Amgen Japan; Head of Corporate Strategic Planning; Chief Operations Officer of Amgen BioPharma; and Vice President, Licensing and Business Development. Mr. Narachi received a BS in Biology and an MA degree in Biology and Genetics from the University of California at Davis. He received an MBA from the Anderson Graduate School of Management at University of California, Los Angeles. </p>
</div>
</div>
</div>
<!-- POPUP Deptula -->
<div class="popupbio" style="display:none">
<div id="popup_deptula">
<div class="popupcontent">
<h2>Barbara Deptula</h2>
<h3>Former Executive Vice President and Chief Corporate Development Officer of Shire plc.</h3>
<p>Ms. Deptula brings to the AMAG board broad-based corporate development expertise obtained through her distinguished 30-year career in a variety of biotechnology and multi-national pharmaceutical organizations. Ms. Deptula began working at Shire Pharmaceuticals in 2004, and retired in 2012 from her position as executive vice president and chief corporate development officer, and a member of Shire’s leadership team. During her tenure at Shire, the company deployed nearly five billion dollars acquiring a range of companies and products, and established an independent venture capital arm. Prior to joining Shire, Ms. Deptula was president of the biotechnology division of Sicor Inc. and senior vice president for commercial and product development at Coley Pharmaceutical Group. She also held senior management positions focused on marketing, product development, licensing and business development at US Bioscience, Schering Plough, American Cyanamid, and Genetics Institute. Ms. Deptula received her master’s degree in business administration from the University of Chicago and a bachelor's of science degree from the University of Connecticut's School of Pharmacy.</p>
</div>
</div>
</div>
<!-- POPUP Heiden -->
<div class="popupbio" style="display:none">
<div id="popup_heiden">
<div class="popupcontent">
<h2>William K. Heiden</h2>
<h3>President and Chief Executive Officer of AMAG</h3>
<p>Mr. Heiden is an experienced pharmaceutical and biotechnology executive who joined AMAG in May 2012 as our president and chief executive
officer. Mr. Heiden is also a member of AMAG's board of directors. Mr. Heiden joined AMAG from GTC Biotherapeutics, Inc., where he had served as president and chief executive officer since June 2010. Mr. Heiden has served and will continue to serve as chairman of GTC Biotherapeutics following commencement of his employment with AMAG. Prior to joining GTC Biotherapeutics, Mr. Heiden was the president and chief executive officer and a member of the board of directors of Elixir Pharmaceuticals, Inc., a pharmaceutical company, from September 2004 until December 2008. </p>
<p>Prior to joining Elixir Pharmaceuticals, Mr. Heiden served as president and chief operating officer of Praecis Pharmaceuticals Incorporated (which was acquired by GlaxoSmithKline plc), from 2002 to 2004. From 1987 to 2002, Mr. Heiden progressed through various positions of increasing responsibility at Schering-Plough Corporation (now Merck & Co.), including managing a number of businesses in the United States, Europe and Canada. Mr. Heiden serves on the board of directors of LFB Biotechnologies S.A.S., a private French biotechnology company. Mr. Heiden holds an M.B.A. from Cornell University's
Johnson Graduate School of Management, a M.I.M. degree from the University of Louvain and a B.A. degree from the University of Florida. </p>
</div>
</div>
</div>
<!-- POPUP Perez -->
<div class="popupbio" style="display:none">
<div id="popup_perez">
<div class="popupcontent">
<h2>Robert J. Perez</h2>
<h3>Executive Vice President, Chief Operating Officer, Cubist Pharmaceuticals, Inc.</h3>
<p>Robert J. Perez has been a director since January 2009.</p>
<p>Mr. Perez is currently President and Chief Operating Officer of Cubist Pharmaceuticals, Inc. Mr. Perez joined Cubist in 2003, as Senior Vice President, Sales and Marketing and led the launch of Cubicin® (daptomycin for injection). Prior to joining Cubist, he served as Vice President of Biogen, Inc.'s CNS Business Unit from 2001 to 2003, where he was responsible for commercial leadership of an $800 million neurology business unit and from 1995 to 2001, held positions of increasing responsibility within the commercial organization. From 1987 to 1995, Mr. Perez held various sales and marketing positions at Zeneca Pharmaceuticals. Mr. Perez is currently a member of the Board of Trustees of the Dana-Farber Cancer Institute, Inc., the Board of Advisors of the Citizen School of Massachusetts and a Board member for the Biomedical Science Careers Program. Mr. Perez received a B.S. from California State University, Los Angeles and an MBA from The Anderson School at UCLA.</p>
</div>
</div>
</div>
<!-- POPUP Russell -->
<div class="popupbio" style="display:none">
<div id="popup_russell">
<div class="popupcontent">
<h2>Dr. Lesley Russell</h2>
<h3>Former SVP, Head of R&D for Global Branded Products, Teva Pharmaceuticals</h3>
<p>Since August 2013, Dr. Russell has served as the Chief Operating Officer of TetraLogics Pharmaceuticals, a privately held biopharmaceutical company. Until June 2012, Dr. Russell served as Senior Vice President and Head of R&D for Global Branded Products at Teva Pharmaceuticals, Inc. She was appointed to this role in October 2011 after Teva acquired Cephalon, where she served as Executive Vice President and Chief Medical Officer. Prior to joining Cephalon in 2000, Dr. Russell worked for several pharmaceutical organizations, including US Biosciences, Eli Lilly and Amgen. Before joining the pharmaceutical industry, she was trained in hematology/oncology at Royal Infirmary of Edinburgh and at Royal Hospital for Sick Children in Edinburgh, UK and was a Research Fellow at University of Edinburgh Faculty of Medicine. Dr. Russell currently serves on the Board of Directors of Endoycte, Inc. Dr. Russell received a MB.Ch.B. degree from the University of Edinburgh, Scotland, Faculty of Medicine. She is a member of the Royal College of Physicians, UK, and is registered with the General Medical Council, UK.</p>
</div>
</div>
</div>
<!-- POPUP Santini -->
<div class="popupbio" style="display:none">
<div id="popup_santini">
<div class="popupcontent">
<h2>Gino Santini</h2>
<h3>Retired Eli Lilly and Company Executive; Most recently SVP, Corporate Strategy and Business Development</h3>
<p>Mr. Santini has been a director since February 2012.</p>
<p>In 2010, Mr. Santini retired from distinguished career with Eli Lilly and Company that spanned nearly three decades. During his tenure at Lilly, Mr. Santini held various leadership positions of increasing responsibility, including manager of various international regions, senior vice president of corporate strategy and policy, president of the women’s health franchise and president of U.S. operations. Mr. Santini capped his career at Lilly as a member of the company’s executive committee and as the senior vice president of corporate strategy and business development. Mr. Santini currently serves on the Boards of Directors of Allena Pharmaceuticals, Inc., Sorin S.p.A. and Finanziaria Saccarifera Italo Iberica S.p.A. Mr. Santini, fluent in four languages, holds an undergraduate degree in mechanical engineering from the University of Bologna and a master’s in business administration from the University of Rochester.</p>
</div>
</div>
</div>
<!-- POPUP Scoon -->
<div class="popupbio" style="display:none">
<div id="popup_scoon">
<div class="popupcontent">
<h2>Frank E. Thomas</h2>
<h3>Non-Executive Chairman, Board of Directors Tufts Health Plan</h3>
<p>Davey S. Scoon, C.P.A. has been a director since December 2006.</p>
<p>Mr. Scoon serves as Chairman of the Board of Directors of Tufts Health Plan, where he has been a director since 1981. He also serves as Chairman of the Board of Trustees of Allianz Funds where he has been a director since 2006. Mr. Scoon is also the Chairman of the Audit committee and a member of the Board of Directors of Orthofix International, N.V. and Biodel Inc. He has been an Adjunct Professor at the University of Wisconsin-Madison School of Business since 2010. From 2003 to 2005, Mr. Scoon was Chief Administrative and Financial Officer of Tom's of Maine, a company that manufactures natural care products. From 2001 to 2003, Mr. Scoon served as Chief Financial and Administrative Officer for Sun Life Financial U.S. and from 1999 to 2001, Mr. Scoon served as Vice President and Chief Financial Officer for Sun Life Financial U.S. From 1985 to 1999, Mr. Scoon was employed by Liberty Funds Group of Boston (formerly Colonial Management) in various capacities including Chief Financial Officer and Chief Operating Officer. Mr. Scoon holds a B.B.A. from the University of Wisconsin and an M.B.A. from the Harvard Business School.</p>
</div>
</div>
</div>
<div class="bottom-block" style="clear: both; margin-right: 15px;">
<ul>
<li>© 2013 AMAG Pharmaceuticals Inc.</li>
<li><a href="../about/terms.html">Terms and Conditions</a></li>
<li><a href="../about/privacy.html">Privacy Policy</a></li>
</ul>
</div>
</div>
<!-- twocolumns sidebar
<div id="sidebar">
<div class="callout-block">
<p><strong>AMAG Pharmaceuticals is committed to improving the health outcomes of patients through the development commercialization of specialty pharmaceutical products.</strong></p>
</div>
<div class="image-holder">
<img src="../images/imgabout_pageright.jpg" alt="photo" width="147" height="163" />
</div>
</div>-->
</div>
<!-- aside -->
<div class="aside">
<!-- sub-navigation -->
<ul class="sub-nav">
<li><a href="../about/mission.html">mission</a></li>
<li><a href="../about/leadership.html">leadership team</a></li>
<li class="active"><a href="../about/board.html">board of directors</a></li>
<li><a href="../about/directions.html">directions</a></li>
<li><a href="../about/contact.html">contact us</a></li>
</ul>
<div class="image-holder">
<img src="../images/imgabout_pageleft.jpg" alt="photo" width="159" height="345" />
<span class="image-overlay"></span>
</div>
</div>
</div>
</div>
</div>
</div>
<script type="text/javascript">
var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www.");
document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E"));
</script>
<script type="text/javascript">
try {
var pageTracker = _gat._getTracker("UA-8258819-1");
pageTracker._trackPageview();
} catch(err) {}
</script>
</body>
</html>